wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28534786-6CC26E73-9D05-42A6-8A56-1A11F057A2CE
Q28534786-6CC26E73-9D05-42A6-8A56-1A11F057A2CE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28534786-6CC26E73-9D05-42A6-8A56-1A11F057A2CE
Ixabepilone administered weekly or every three weeks in HER2-negative metastatic breast cancer patients; a randomized non-comparative phase II trial
P2860
Q28534786-6CC26E73-9D05-42A6-8A56-1A11F057A2CE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28534786-6CC26E73-9D05-42A6-8A56-1A11F057A2CE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
853015b46ac932dfea0fb06e92905d63325fe7e2
P2860
Ixabepilone development across the breast cancer continuum: a paradigm shift.